Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_094e24e73146c7c40113557c1a4658aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
filingDate |
2011-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f10a209f3713e07ceb58a82e226442c3 |
publicationDate |
2012-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2012004188-A1 |
titleOfInvention |
Use of ranolazine for treating pulmonary hypertension |
abstract |
This disclosure relates generally to treating patients having pulmonary hypertension such as pulmonary arterial hypertension (PAH), or symptoms associated therewith, by administering a therapeutically effective amount of ranolazine or a salt or salts thereof to the patient. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10709341-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9198908-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8883750-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013142387-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10881645-B2 |
priorityDate |
2010-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |